NR601 Final Exam
Prostate Cancer staging ANS: A No palpable lesion, biopsy only
B1 Palpable nodule 1 lobe
B2 Palpable nodule both lobes or one dominant nodule >1.5 cm
C Locally advanced, invading the capsule
D1 Extracapsular involves pelvic lymph nodes
D1.5 Chemical recurrence, rising PSA after prostatectomy
D2 Extensive retroperitoneal lymph node involvement, distant metastasis
D2.5 Rising PSA after definitive treatment
Prostate cancer screening ANS: Screen PSA for asymptomatic men
Prostate Cancer treatment ANS: Hormonal treatment mainstay for metastatic prostate cancer
Prostate cancer- Gleason score of 7 ANS: Close observation for patients with localized disease and men
age 70+ with well- differentiated tumor
Colon cancer staging ANS: based on tumor sizes, nodes involved, metastasis present
Colon cancer long term surveillence ANS: All patients who have had a curative resection of cancer of the
large bowel should undergo surveillance colonoscopy. The first examination is generally performed 1
year after surgery
the other examinations are performed at 3- to 5-year intervals.
Yearly abdominal CT and periodic determinations of CEA for 5 years
, Medications that prevent breast cancer ANS: SERMs, including tamoxifen and raloxifene, and AIs,
including anastrozole, letrozole, and exemestane, may prevent breast cancer
Medications that may prevent prostate cancer ANS: Finasteride
Medications that may prevent colon cancer ANS: COX2 inhibitors and aspirin
Prostate Cancer- Gleason score 8+ ANS: poorly differentiated tumor extra capsular involvement beyond
the seminal vesicles and PSA >30
poor prognostic factors
Treatment for chlamydia and gonorrhea ANS: ceftriaxone 250 mg IM once + doxycycline 100mg BID x7
days
Gay men screening ANS: An HPV (human papillomavirus)-related cancer, anal cancer is more common in
MSM because of lifetime exposure to HPV through receptive anal intercourse.
HIV positive populations and pap smears ANS: In HIV-positive MSM populations, annual anal Pap smears
are suggested and can also be considered in HIV-positive women with history of receptive anal
intercourse, abnormal cervical Pap smears, or history of genital warts (grade C)
Why is there an increased risk of breast cancer in WSW populations? ANS: there may be more prevalent
risk factors, such as nulliparity, alcohol use, smoking, and obesity in lesbian women when compared
with heterosexual women.
Breast cancer screening ANS: biennial screening mammography for women age 50 to 74 years. age 75
and up it is patient preference
Prostate Cancer staging ANS: A No palpable lesion, biopsy only
B1 Palpable nodule 1 lobe
B2 Palpable nodule both lobes or one dominant nodule >1.5 cm
C Locally advanced, invading the capsule
D1 Extracapsular involves pelvic lymph nodes
D1.5 Chemical recurrence, rising PSA after prostatectomy
D2 Extensive retroperitoneal lymph node involvement, distant metastasis
D2.5 Rising PSA after definitive treatment
Prostate cancer screening ANS: Screen PSA for asymptomatic men
Prostate Cancer treatment ANS: Hormonal treatment mainstay for metastatic prostate cancer
Prostate cancer- Gleason score of 7 ANS: Close observation for patients with localized disease and men
age 70+ with well- differentiated tumor
Colon cancer staging ANS: based on tumor sizes, nodes involved, metastasis present
Colon cancer long term surveillence ANS: All patients who have had a curative resection of cancer of the
large bowel should undergo surveillance colonoscopy. The first examination is generally performed 1
year after surgery
the other examinations are performed at 3- to 5-year intervals.
Yearly abdominal CT and periodic determinations of CEA for 5 years
, Medications that prevent breast cancer ANS: SERMs, including tamoxifen and raloxifene, and AIs,
including anastrozole, letrozole, and exemestane, may prevent breast cancer
Medications that may prevent prostate cancer ANS: Finasteride
Medications that may prevent colon cancer ANS: COX2 inhibitors and aspirin
Prostate Cancer- Gleason score 8+ ANS: poorly differentiated tumor extra capsular involvement beyond
the seminal vesicles and PSA >30
poor prognostic factors
Treatment for chlamydia and gonorrhea ANS: ceftriaxone 250 mg IM once + doxycycline 100mg BID x7
days
Gay men screening ANS: An HPV (human papillomavirus)-related cancer, anal cancer is more common in
MSM because of lifetime exposure to HPV through receptive anal intercourse.
HIV positive populations and pap smears ANS: In HIV-positive MSM populations, annual anal Pap smears
are suggested and can also be considered in HIV-positive women with history of receptive anal
intercourse, abnormal cervical Pap smears, or history of genital warts (grade C)
Why is there an increased risk of breast cancer in WSW populations? ANS: there may be more prevalent
risk factors, such as nulliparity, alcohol use, smoking, and obesity in lesbian women when compared
with heterosexual women.
Breast cancer screening ANS: biennial screening mammography for women age 50 to 74 years. age 75
and up it is patient preference
